AzTrials
AzTrials

Emotional DistressRT-CANCT07143357

Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest

A study testing Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 in people with Emotional Distress and Cardiac Arrest (CA), run by Icahn School of Medicine at Mount Sinai at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The purpose of this study is to pilot two resilience interventions for cardiac arrest survivors and their informal caregivers, Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 . The data the investigators gather in this study will be used to further refine the interventions. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Emotional Distress, Cardiac Arrest (CA), Anxiety
What is being tested?
Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
2 sitesUnited States
Study dates
17 Oct 2025to Jun 2028
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Out-of-hospital or in-hospital CA survivor (must have new diagnosis of "cardiac arrest" in electronic medical record from index hospitalization with documented loss of pulse) with an identified caregiver (identified by the survivor who is their primary source of emotional and functional support)
  • survivor must score >5 on Short Form of the Mini Mental State Exam for sufficient cognitive function for meaningful participation
  • ability and willingness to participate in a hybrid in-person/live video intervention
  • English speaking adults (18 year or older)
  • at least one member of the dyad endorses clinically significant emotional distress during screening (>7 on either of the Hospital Anxiety and Depression Scale subscales).

Who cannot join

  • active psychosis, mania, substance dependence, or suicidal intent or plan that would require a higher level of care
  • any other psychiatric or neurological condition that would preclude meaningful participation
  • the caregiver must not be a cardiac arrest survivor

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites, 1 recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

    Completed
  • Mount Sinai Health System

    New York, New York, 10029

    Recruiting

Other trials in United States

About this study

Official title: Development of a Dyadic Mind-body Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest (RT-CA).

The purpose of this study is to pilot two resilience interventions for cardiac arrest survivors and their informal caregivers, Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 . The data the investigators gather in this study will be used to further refine the interventions.

Read the detailed description

The goal of this study is to test the feasibility of the proposed interventions through a pilot RCT. The investigators will deliver the RCT intervention (N=42 dyads; 84 participants total) and evaluate feasibility and acceptability based on a priori benchmarks.

The RCT takes place initially in intensive care units and step-down units then progresses to Zoom once survivors are discharged. Cardiac arrest survivor-caregiver dyads will be randomly assigned to one of two groups - Recovering Together after Cardiac Arrest 1 (RT-CA 1) or Recovering Together after Cardiac Arrest 2 (RT-CA 2).

RT-CA 1 involves six, 30-minute weekly sessions beginning at bedside and continuing over Zoom after the survivor is discharged. RT-CA 2 involves one, 30 minute session at bedside.

All participants will complete psychosocial survey measures at baseline, six weeks, and 3 months.

Being tested
Recovering Together after Cardiac Arrest 1, Recovering Together after Cardiac Arrest 2
Keywords
emotional distress, cardiac arrest, cardiac arrest survivorship, caregivers, resilience, mindfulness, mind-body, behavioral interventions, anxiety, depression
Medical subject headings
Heart Arrest, Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Recovering Together after Cardiac Arrest 1Behavioural

    The intervention will teach resiliency skills (mindfulness and coping) to dyads and provider anticipatory guidance and resources to manage stressors specific to cardiac arrest. These sessions will take place in person until the survivor is discharged; remaining sessions will occur over Zoom.

  • Recovering Together after Cardiac Arrest 2Other

    In this minimally enhanced usual care control, dyads will participate in one 30-minute session with a clinician at beside to review a pamphlet of available psychosocial resources for cardiac arrest survivors and their caregivers.

Study groups in NCT07143357
Study groupRoleWhat they receive
Recovering Together after Cardiac Arrest 1ExperimentalDyads will participate in 6 30-minute skills-based sessions. Sessions will also include provision of anticipatory guidance and resources to manage cardiac arrest-specific stressors. A clinical psychologist will deliver all of the sessions. The main intervention goal is to provide dyads with resiliency skills and resources to reduce emotional distress and prevent chronic distress.
Receives: Behavioral: Recovering Together after Cardiac Arrest 1
Recovering Together after Cardiac Arrest 2OtherRecovering Together after Cardiac Arrest is a minimally enhanced usual care control. Dyads will participate in one 30-minute session with a clinician reviewing available psychosocial resources for cardiac arrest survivors and their caregivers.
Receives: Other: Recovering Together after Cardiac Arrest 2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of Recruitment

    Proportion of eligible dyads that consent to participation

    Measured: pre-test

  2. Feasibility of Randomization

    Proportion of randomized participants who submit post-test assessments

    Measured: The end of treatment at 6 weeks

  3. Feasibility of Assessment Completion

    Proportion of participants with no assessment measures missing at pre-test, post-test, and 3 month follow-up

    Measured: pre-test, the end of treatment at 6 weeks, and 3 months after the end of treatment

  4. Feasibility of Program Adherence (RT-CA 1)

    Proportion of RT-CA 1 dyads that initiate the program by attending session 1 and complete at least 4 of 6 sessions.

    Measured: the end of treatment at 6 weeks

  5. Therapist Fidelity

    Proportion of 20% randomly-selected RT-CA 1 sessions in which the therapist fully adheres to program content, ascertained by a fidelity checklist

    Measured: the end of treatment at 6 weeks

  6. Treatment Satisfaction (RT-CA 1)

    Proportion of RT-CA 1 participants that endorse satisfaction, defined as above the midpoint on the Client Satisfaction Questionnaire-3

    Measured: the end of treatment at 6 weeks

  7. Credibility (RT-CA 1)

    Proportion of RT-CA 1 participants that endorse program credibility at pre-test, defined as scoring above the midpoint on the Credibility sub scale of the Credibility/Expectancy Questionnaire which is scored from 3-27; higher scores indicate greater credibility.

    Measured: pre-test

  8. Expectancy (RT-CA 1)

    Proportion of RT-CA 1 participants that endorse expectancy to improve. from the program at pre-test, defined as scoring above the midpoint on the Expectancy sub scale of the Credibility/Expectancy Questionnaire which is scored from 3-27; higher scores indicate greater expectancy.

    Measured: pre-test

  9. Study safety

    The proportion of participants that report no adverse events related to study participation.

    Measured: at the end of treatment at 6 weeks and 3 months after the end of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2025
  2. Study start17 Oct 2025
  3. Primary completionJun 2028 (estimated)
  4. Study completionJun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07143357
Sponsor's protocol ID
STUDY-26-00513
Other IDs
5K23AT012487, 2025P002063
Acronym
RT-CA
Status last verified
Oct 2026
First submitted
5 Aug 2025
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be shared upon reasonable request.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in